Extended Data Table 3 Circulating tumor cells enumeration, composition, and digoxin serum levels in the treated patients

From: Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial

  1. Table describing the volume of blood analyzed, the total number of single CTCs, the total number of CTC clusters, the number of homotypic CTC clusters and the number of heterotypic CTC-WBC clusters per 7.5 ml of peripheral blood, the average cluster size and digoxin serum levels. Pre-treatment value is the calculated average of Screening and 0-pre-dose values, when both were available. NA: not available.
Back to article page